T1	Participants 248 437	19 ambulatory men with moderated essential hypertension (supine diastolic blood pressure [DPB], 100 to 120 mm Hg after receiving placebo for two weeks) whose sodium intake was unrestricted.
T2	Participants 438 511	The captopril group included 12 patients and the propranolol group seven.
T3	Participants 605 639	eight patients receiving captopril
T4	Participants 647 689	four of the patients receiving propranolol
T5	Participants 1032 1091	one patient in whom proteinuria developed after seven weeks
